Skip to content

SCHEDULE 13D/AAccepted Apr 30, 4:29 PM ET

Aerovate Therapeutics, Inc. SCHEDULE 13D/A

Atlas Venture Fund XII, L.P.

Accepted (ET)

4:29 PM

Apr 30, 2025

Filed

Apr 30, 2025

Documents

1

Size

12.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.